Aug 12, 2026 04:14PM
Aug 12, 2026 04:05PM
Aug 5, 2026 07:00AM
May 12, 2026 04:33PM
May 12, 2026 04:05PM
May 5, 2026 07:00AM
Mar 5, 2026 04:09PM Aviragen Therapeutics (AVIR) Misses Q4 EPS by 13c
Mar 5, 2026 04:05PM
Feb 26, 2026 07:00AM
Nov 12, 2025 04:12PM
Nov 12, 2025 04:05PM
Nov 5, 2025 07:00AM
Aug 7, 2025 04:09PM
Aug 7, 2025 04:05PM Atea Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
Jul 31, 2025 07:00AM
May 12, 2025 04:54PM
May 12, 2025 04:11PM
May 1, 2025 07:00AM
Mar 6, 2025 04:11PM
Mar 6, 2025 04:05PM
Feb 27, 2025 07:00AM Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on March 6, 2025
Nov 7, 2024 04:26PM
Nov 7, 2024 04:05PM
Oct 31, 2024 07:00AM
Aug 7, 2024 04:13PM
Aug 7, 2024 04:05PM
Jul 31, 2024 07:00AM
May 14, 2024 04:06PM Aviragen Therapeutics (AVIR) Misses Q1 EPS by 14c
May 14, 2024 04:05PM
May 7, 2024 07:00AM
Feb 28, 2024 04:09PM
Feb 28, 2024 04:05PM
Feb 21, 2024 07:00AM
Nov 8, 2023 04:23PM
Nov 8, 2023 04:05PM Atea Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
Nov 1, 2023 07:00AM
Aug 8, 2023 04:23PM
Aug 8, 2023 04:05PM
Aug 1, 2023 07:00AM
May 23, 2023 04:05PM
May 23, 2023 04:05PM
May 8, 2023 04:05PM Atea Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update
May 1, 2023 04:05PM
Feb 28, 2023 04:34PM
Feb 28, 2023 04:05PM
Feb 21, 2023 07:00AM
Nov 7, 2022 04:05PM
Oct 31, 2022 07:00AM
Aug 8, 2022 04:34PM Aviragen Therapeutics (AVIR) Tops Q2 EPS by 11c
Aug 8, 2022 04:05PM

1,222,851 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All